Parexel launches IMPACT CTMS
Parexel International, a global biopharmaceutical services provider, has introduced IMPACT Express Clinical Trial Management System (CTMS). IMPACT Express provides a quick-to-implement, cost-effective clinical trial management solution to simplify clinical trial management and monitoring for small to mid-sized biopharmaceutical companies.
Clinical trials are the most expensive component of the drug development process. Use of a single, unified clinical trial management system plays a vital role in helping biopharmaceutical companies plan, track, record and oversee the complex array of administrative, financial, site-related and other activities that are critical for the efficient monitoring and management of clinical trials.
“Parexel developed IMPACT Express for biopharmaceutical and biotech companies in need of a scalable, rapid-to-deploy and cost-effective CTMS option to intelligently manage the complexities of clinical trials,” said Patrick Nadolny, vice president of product management, data and analytics services for Parexel Informatics. “By applying a process-driven approach to trial management and monitoring, biopharma companies will be better able to save time—and money—while simplifying their drug development journey.”
IMPACT Express draws on Parexel Informatics’ commitment to operational excellence and 20-plus years of investment in CTMS innovations and process improvements coupled with the feedback and hands-on experiences of users around the world. Biopharmaceutical, medical device and research organizations of all sizes have used Parexel’s CTMS solutions to manage more than 25,000 trials.